PARIS--(BUSINESS WIRE)--With the installation of a machine sold for biomedical applications,
Prodways also supplied a first batch of resin fully designed, developed
and produced in-house. This resin will be assessed in order to be
qualified for the manufacturing of biomedical products which are likely
to require several hundreds of kilograms of resin per year for
production purposes, for this first machine only.
The material supplied is the first to be marketed in the range of proprietary resins developed in-house and will represent the core material offered by the group. The Prodways materials strategy is half-open to materials from third parties, which must be approved by Prodways, thereby enabling the group's customers to enjoy the best solutions available on the market.
Accordingly, Prodways will continue to give customers access to resins developed by other partners and the group will continue to sell resins used by competitor machines, which still accounts for the largest share of current revenue in terms of the sale of materials.
The French customer - the first user of the group's proprietary resins - ordered three machines in 2014. Two of them were announced in previous press releases.
About Groupe Gorgé:
Established in 1990, Group Gorgé is an industrial group operating in different areas of expertise: Smart Safety Systems, Protection in Nuclear Environments, Industrial Projects & Services and 3D Printing
In 2013, the Group reported revenue of €214.5 million. It is backed by 1,300 employees and operations in over ten countries. Groupe Gorgé is listed on NYSE Euronext Paris (ISIN: FR0000062671; Ticker code: GOE) and on the US OTC market (ISIN: US3994511034; OTC Pink: GGRGY / GGRGF) in the form of ADR.
More information available on www.groupe-gorge.com